Literature DB >> 34544802

Cutting Edge: Intestinal IL-17A Receptor Signaling Specifically Regulates High-Fat Diet-Mediated, Microbiota-Driven Metabolic Disorders.

Stephen J Gaudino1, Huakang Huang1, Makheni Jean-Pierre1, Preet Joshi1, Michael Beaupre1, Cody Kempen1, Hoi Tong Wong1, Pawan Kumar2.   

Abstract

Previous studies indicate that IL-17A plays an important role in mediating the intestinal microbiota and systemic metabolic functions. However, it is not known where IL-17RA signaling occurs to mediate these effects. To investigate this question, we used intestinal epithelial-specific (Il17ra ΔIEC ) and liver-specific (Il17raΔLiver ) IL-17RA knockout mice as well as littermate control mice. Our results indicate that intestinal IL-17RA signaling helps mediate systemic metabolic functions upon exposure to prolonged high-fat diet. Il17ra ΔIEC mice display impaired glucose metabolism, altered hormone and adipokine levels, increased visceral adiposity, and greater hepatic lipid deposition when compared with their littermate controls. We show that IL-17RA-driven changes in microbiota composition are responsible for regulating systemic glucose metabolism. Altogether, our data elucidate the importance of intestinal IL-17RA signaling in regulating high-fat diet-mediated systemic glucose and lipid metabolism.
Copyright © 2021 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34544802      PMCID: PMC8556717          DOI: 10.4049/jimmunol.2000986

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.426


  26 in total

1.  Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22.

Authors:  Ling Yang; Yixuan Zhang; Lingdi Wang; Fengjuan Fan; Lu Zhu; Zhigang Li; Xiangbo Ruan; Heng Huang; Zhenzhen Wang; Zhihua Huang; Yuliang Huang; Xiaoqiang Yan; Yan Chen
Journal:  J Hepatol       Date:  2010-04-21       Impact factor: 25.083

2.  Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes.

Authors:  Xiaoting Wang; Naruhisa Ota; Paolo Manzanillo; Lance Kates; Jose Zavala-Solorio; Celine Eidenschenk; Juan Zhang; Justin Lesch; Wyne P Lee; Jed Ross; Lauri Diehl; Nicholas van Bruggen; Ganesh Kolumam; Wenjun Ouyang
Journal:  Nature       Date:  2014-08-06       Impact factor: 49.962

Review 3.  Recent progress in genetics, epigenetics and metagenomics unveils the pathophysiology of human obesity.

Authors:  Marie Pigeyre; Fereshteh T Yazdi; Yuvreet Kaur; David Meyre
Journal:  Clin Sci (Lond)       Date:  2016-06-01       Impact factor: 6.124

4.  The gut microbiota as an environmental factor that regulates fat storage.

Authors:  Fredrik Bäckhed; Hao Ding; Ting Wang; Lora V Hooper; Gou Young Koh; Andras Nagy; Clay F Semenkovich; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-25       Impact factor: 11.205

5.  Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis.

Authors:  Yun Kyung Lee; Juscilene S Menezes; Yoshinori Umesaki; Sarkis K Mazmanian
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-26       Impact factor: 11.205

Review 6.  Leptin effects on pancreatic beta-cell gene expression and function.

Authors:  Jochen Seufert
Journal:  Diabetes       Date:  2004-02       Impact factor: 9.461

7.  Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice.

Authors:  Patrice D Cani; Rodrigo Bibiloni; Claude Knauf; Aurélie Waget; Audrey M Neyrinck; Nathalie M Delzenne; Rémy Burcelin
Journal:  Diabetes       Date:  2008-02-27       Impact factor: 9.461

Review 8.  Leptin and mucosal immunity.

Authors:  N M Mackey-Lawrence; W A Petri
Journal:  Mucosal Immunol       Date:  2012-06-13       Impact factor: 7.313

9.  Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice.

Authors:  Amandine Everard; Vladimir Lazarevic; Muriel Derrien; Myriam Girard; Giulio G Muccioli; Giulio M Muccioli; Audrey M Neyrinck; Sam Possemiers; Ann Van Holle; Patrice François; Willem M de Vos; Nathalie M Delzenne; Jacques Schrenzel; Patrice D Cani
Journal:  Diabetes       Date:  2011-09-20       Impact factor: 9.461

10.  Bacteroides uniformis CECT 7771 ameliorates metabolic and immunological dysfunction in mice with high-fat-diet induced obesity.

Authors:  Paola Gauffin Cano; Arlette Santacruz; Ángela Moya; Yolanda Sanz
Journal:  PLoS One       Date:  2012-07-26       Impact factor: 3.240

View more
  1 in total

Review 1.  Interleukin-17 Family Cytokines in Metabolic Disorders and Cancer.

Authors:  Eileen Victoria Meehan; Kepeng Wang
Journal:  Genes (Basel)       Date:  2022-09-13       Impact factor: 4.141

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.